Biotech Values

[acgood]

Since I happened to be listening to the webcast when you posted this, I guess that means I should reply.

I'd agree that this isn't a deal that I would have expected. It makes total sense for WPI, but I don't really see what AMGN gets out of the deal (they certainly didn't need the cash contribution), except maybe someone to hold hands with as they jump off the cliff.

Of course, this deal knocks two of my "wildcards" for a MNTA deal off the list in one fell swoop:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69375925
So now I'll oblige you and move wildcard below MRK and SNY on the list.

I was interested in the discussion around the TNF biologics. Do you have a guess as to why they would do a cancer deal excluding AMGN oncology drugs, but not include TNF drugs while excluding enbrel?